Coronavirus Vaccine Market, By Vaccine Type, By Distribution Channel, By Geography

PUBLISHED: March 25, 2025

PAGES: 170 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Coronavirus Vaccine Market is estimated to be valued at USD 50.64 Bn in 2025 and is expected to reach USD 83.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 50.64 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	USD 83.47 Bn

The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. COVID-19 is a viral infection caused by a coronavirus called SARS-CoV-2, which affects the respiratory tract. The COVID-19 is highly contagious and can be transmitted through direct contact with the infected person or indirect contact with surfaces in the immediate environment. Moreover, the number of people getting infected by COVID-19 has dynamically increased, making it a global pandemic. For instance, according to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 169 million cases and 3.5 million deaths due to coronavirus disease (COVID-19) were reported up till May 30, 2021 across the globe.

Market Dynamics

Market players are conducting clinical trials for developing more efficient vaccines against COVID-19, which could contribute to the growth of the market over the forecast period. For instance, in December, Zydus Cadila announced that ZyCoV-D vaccine cleared phase 1 and phase 2 trials. The company's plasmid DNA vaccine to prevent COVID-19, was found to be safe, well tolerated, and immunogenic in phase 1 and 2.

Market players are focusing on product launch and approvals, which is expected to strengthen their position in the global market. For instance, in December 2020, AstraZeneca's COVID-19 vaccine was approved for emergency supply in the U.K., with the first doses being released, so that vaccinations may begin by early 2021. The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) provided authorization for emergency supply of COVID-19 vaccine AstraZeneca, formerly AZD1222, for the active immunization of individuals 18 years or older. The authorization recommends two doses administered in an interval of between four and 12 weeks.

Market players are involved in inorganic growth strategies such as partnerships, collaborations, mergers, and acquisitions, in order to enhance distribution of COVID 19 vaccines. This is expected to drive the growth of the coronavirus vaccine market. For instance, on August 14, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) entered into an agreement with Moderna, Inc. to manufacture and deliver 100 million doses of COVID-19 vaccines produced by the company in the U.S. by 2021.

Key features of the study:

This report provides in-depth analysis of the global coronavirus vaccine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period 2025-2032.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global coronavirus vaccine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Key companies covered as a part of this study include Sinovac Biotech Ltd., Bharat Biotech International Limited, BioNTech SE, CanSinoBIO, CureVac AG, Zydus Cadila, AstraZeneca Plc, Arcturus Therapeutics Holdings Inc., Entos Pharmaceuticals, Symvivo, Novavax, Inc., Moderna, Inc., Johnson & Johnson, Sanofi S.A., Pfizer, Inc., and Serum Institute of India Pvt. Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
The global coronavirus vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global coronavirus vaccine market

Detailed Segmentation:

Global Coronavirus Vaccine Market, By Vaccine Type:
- Inactivated Virus
- Protein Subunit
- Non-replicating Viral Vector
- Repurposed Vaccines
- RNA Vaccine
- DNA Vaccine
Global Coronavirus Vaccine Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Sinovac Biotech Ltd.
- Bharat Biotech International Limited
- BioNTech SE
- CanSinoBIO
- CureVac AG
- Zydus Cadila
- AstraZeneca Plc
- Arcturus Therapeutics Holdings Inc.
- Entos Pharmaceuticals
- Symvivo
- Novavax, Inc.
- Moderna, Inc.
- Johnson & Johnson
- Sanofi S.A.
- Pfizer, Inc.
- Serum Institute of India Pvt. Ltd.

Product Code: CMI4320

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Coronavirus Vaccine Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Coronavirus Vaccine Market, By Vaccine Type, 2020- 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Inactivated Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Protein Subunit
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Non-replicating Viral Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Repurposed Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
RNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

6. Global Coronavirus Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Government Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Hospital and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Coronavirus Vaccine Market, By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 -2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Pfizer-BioNtech
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AstraZeneca
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bharat Biotech
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Johnson & Johnson Services, Inc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Moderna, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sinovac Biotech Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sanofi S.A.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novavax, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Symvivo
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CanSinoBIO
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CureVac AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Zydus Cadila
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Arcturus Therapeutics Holdings Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Entos Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies